Literature DB >> 9048628

Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.

C J Torrance1, J E Devente, J P Jones, G L Dohm.   

Abstract

Previous studies have shown that T3 coordinately stimulates GLUT4-glucose transporter messenger RNA (mRNA) and protein expression in mixed fiber-type skeletal muscle of the rat and produces a concomitant elevation in basal (noninsulin mediated) glucose uptake. The aim of the present study was to 1) determine the precise mechanism(s) for the T3-induced expression of GLUT4 in skeletal muscle, and 2) investigate the potential benefits of T3 on noninsulin dependent diabetes mellitus (NIDDM). Ten daily ip injections of T3 (100 micrograms/100 g BW) administered to hypothyroid male Sprague-Dawley rats, increased both GLUT4 mRNA and transcription approximately 70% (P < 0.05) in mixed fiber-type hindlimb skeletal muscle. Transcriptional induction was subsequently defined to be restricted to red (oxidative) muscle fibers (2.5-fold; P < 0.05), whereas GLUT4 protein was increased in both red and white (glycolytic) skeletal muscle. GLUT4 mRNA and protein expression were similarly inducible in the skeletal muscle of insulin-resistant Zucker rats. More importantly, T3 treatment totally ameliorated hyperinsulinemia in obese animals (P < 0.001), although their moderately elevated plasma glucose levels were not significantly altered. In conclusion, regulation of GLUT4 expression by T3 was shown to lie at the transcriptional level in red skeletal muscle, whereas in white muscle fiber types, it appears to operate via an alternative posttranscriptional mechanism. These data also support the potential of hormonally inducing glucose transporter expression in insulin-resistant muscle. However, high levels of T3 are associated with a number of adverse side-effects, in particular the stimulation of hepatic gluconeogenesis. Nevertheless, future studies may demonstrate, e.g. subthyrotoxic levels, to be similarly effective but without side effects, and thus perhaps find a clinical application in reducing both hyperinsulinemia and hyperglycemia in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048628     DOI: 10.1210/endo.138.3.4981

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.

Authors:  Silvania Silva Teixeira; Akhilesh K Tamrakar; Francemilson Goulart-Silva; Caroline Serrano-Nascimento; Amira Klip; Maria Tereza Nunes
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians.

Authors:  Saraswathy Nair; Yunhua Li Muller; Emilio Ortega; Sayuko Kobes; Clifton Bogardus; Leslie J Baier
Journal:  Thyroid       Date:  2011-12-05       Impact factor: 6.568

3.  Glucose delays the insulin-induced increase in thyroid hormone-mediated signaling in adipose of prolong-fasted elephant seal pups.

Authors:  Bridget Martinez; José G Soñanez-Organis; Jose A Viscarra; John T Jaques; Duncan S MacKenzie; Daniel E Crocker; Rudy M Ortiz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

4.  Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance.

Authors:  Gabriela Brenta; Francesco S Celi; Mario Pisarev; Marta Schnitman; Isaac Sinay; Pablo Arias
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568

5.  Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

Authors:  Daniel F Vatner; Dirk Weismann; Sara A Beddow; Naoki Kumashiro; Derek M Erion; Xiao-Hui Liao; Gary J Grover; Paul Webb; Kevin J Phillips; Roy E Weiss; Jonathan S Bogan; John Baxter; Gerald I Shulman; Varman T Samuel
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

6.  Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I.

Authors:  Kee Kwang Kim; Key Sun Park; Seok Bean Song; Kyoon Eon Kim
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

7.  Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1.

Authors:  L Al-Khalili; M Forsgren; K Kannisto; J R Zierath; F Lönnqvist; A Krook
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

8.  High prevalence of subclinical thyroid dysfunction and the relationship between thyrotropin levels and cardiovascular risk factors in residents of the coastal area of China.

Authors:  Jinqian Wang; Xiuyun Ma; Shuying Qu; Yingzheng Li; Lihui Han; Xun Sun; Peimei Li; Xue Liu; Jinhua Xu
Journal:  Exp Clin Cardiol       Date:  2013

9.  A TRbeta-selective agonist confers resistance to diet-induced obesity.

Authors:  Beatriz S Amorim; Cintia B Ueta; Beatriz C G Freitas; Renata J Nassif; Cecília Helena de Azevedo Gouveia; Marcelo A Christoffolete; Anselmo S Moriscot; Carmen Lucia Lancelloti; Flávia Llimona; Hermes Vieira Barbeiro; Heraldo Possolo de Souza; Sergio Catanozi; Marisa Passarelli; Marcelo S Aoki; Antonio C Bianco; Miriam O Ribeiro
Journal:  J Endocrinol       Date:  2009-08-27       Impact factor: 4.286

10.  Thyroid hormone regulates the expression and function of P-glycoprotein in Caco-2 cells.

Authors:  Naoki Nishio; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2007-11-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.